ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meeting Abstracts
    • All Meetings
    • PRSYM 2026
    • ACR Convergence 2025
    • Download Abstract Supplements
  • Keyword Index
  • My Favorites
    • View & print my favorites
  • Search

Abstracts tagged "interstitial lung disease and KL-6"

  • Abstract Number: 2348 • ACR/ARP Annual Meeting 2019

    KL-6 Is a Useful Marker to Monitor the Progression of RA-ILD, but Not to Diagnose or Predict the Development of ILD

    Yuta Takamura1, Ayae Tanaka 1, Kazuhiro Kurasawa 1, Anna Hasegawa 2, Chika Hiyama 2, Toshiyuki Miyao 1, Ryutaro Yamazaki 1, Satoko Arai 1, Takayoshi Owada 1, Reika Maezawa 1 and Masafumi Arima 2, 1Dokkyo Medical University, Mibu-machi, Shimotsuga-gun, Tochigi, Japan, 2Dokkyo Medical University, Mibu, Tochigi, Japan

    Background/Purpose: Interstitial lung disease (ILD) is a critical comorbidity in RA. To manage RA-ILD, early diagnosis and monitoring disease progression are important. KL-6 is a marker…

My Favorites

Save and print abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract (must have cookies enabled in browser). See saved favorites.

Abstract Policies

  • ACR Convergence Abstract Embargo Policies
  • ACR Convergence Abstract Permissions & Reprints
  • PRSYM Abstract Policies

ACR Convergence. Where Rheumatology Meets

ACR Convergence 2026

Join us November 6-11 in Orlando, Florida.
See Registration Information

  • Contact ACR
  • Privacy Policy
  • ACR Policies
  • Cookie Preferences

© Copyright 2026 American College of Rheumatology